Atrial Rhythm Questions
Questions
(points possible)
|
Answers
Use concise, complete
sentences. Do not exceed 1 page
|
Risk factors: Identify risk factors for atrial
fibrillation (AFIB) the nurse should recognize in the scenario. (10 points)
|
Atrial fibrillation (AFIB) is the most common type of
abnormal heart rhythm, affecting about 2.7 million people in the U.S., with
an estimated incidence of 1% to 2% per year. AFIB is associated with several risk
factors, including older age, male gender, diabetes mellitus, high blood
pressure, and coronary artery disease (Tacklind, 2019). Therefore, the nurse
should recognize the following risk factors for AFIB in this patient:
Age over 65 years old. The incidence of AFIB increases
with age, with a peak incidence at 65 years old and beyond. AFIB is 2- to
6-fold more common in men than women, with a male-to-female ratio of 1:2–3.
Heart failure or left ventricular dysfunction (LV
dysfunction). The incidence of AFIB increases with the severity of LV
dysfunction or heart failure. Paroxysmal and persistent AFIB is more common
in patients with severe heart failure or LV dysfunction than those without
these conditions. Patients who have experienced an acute myocardial
infarction have an increased risk of developing paroxysmal or persistent AFIB
within 3 months after their event.
Heart disease: AFIB is more common in people with heart
disease, particularly those who have had a heart attack or coronary artery
bypass grafting (CABG).
High blood pressure: People with high blood pressure are
at increased risk for AFIB. High blood pressure Diabetes mellitus type II
with mild renal insufficiency Hypothyroidism Admitted to medical-surgical
unit Compliant with medications, diet (diabetic, low salt, low-fat diet), and
physical activity recommendations (Tacklind, 2019).
Obesity: Obesity is associated with an increased risk for
AFIB.
Diabetes: People who have diabetes are at increased risk
for AFIB.
Sleep apnea: Sleep apnea affects breathing during sleep
and can increase AFIB risk (Mayyas et al., 2010).
Other risk factors include obesity, smoking, and alcohol
use. The presence of a heart valve abnormality also increases the risk of
AFIB. Patients with AFIB have significantly higher rates of stroke, heart
failure, and death than those without AFIB.
|
Manifestations
and abnormal results: Identify
the manifestations and abnormal diagnostic results consistent with AFIB the
nurse should recognize in the scenario. (20
points)
|
AFIB is the most
common type of atrial fibrillation and one of the most common cardiac
arrhythmias. It affects about 3 million Americans, mostly older than 60. In
some cases, people have no symptoms from AFIB, but in others, they may
experience symptoms like:
• Shortness of breath or difficulty breathing
• Palpitations or a racing heartbeat
• Chest pain or discomfort
• Fatigue (Tacklind, 2019).
• Dizziness or lightheadedness
• Fainting (syncope) or near-fainting (presyncope)
AFIB is characterized by atrial fibrillation (A.F.), a
heart rhythm abnormality that causes the upper chambers of the heart (atria)
to beat very rapidly and irregularly. AFIB can cause palpitations, shortness
of breath, fatigue, dizziness, lightheadedness, and chest pain. It also
increases the risk of stroke by five times. The nurse should recognize the
following manifestations:
Pulse irregular = 136 beats/minute
Respirations shallow and slightly labored = 30 breaths/min
BP = 108/66 mm Hg (Mayyas, et al., 2010).
Oral temperature = 98.2 ̊ F
Capillary glucose = 115 mg/dL (normal range 70-100 mg/dL)
(Tacklind, 2019).
The nurse should recognize the manifestations and abnormal
diagnostic results consistent with atrial fibrillation (AFIB). The patient is
experiencing dizziness, palpitations, dyspnea, and chest tightness. These are
common signs and symptoms of AFIB. The patient is currently taking metformin
for his Type II diabetes mellitus. Metformin can cause an increase in serum
potassium levels which may be contributing to his current symptoms. Therefore,
monitoring serum potassium levels closely while on metformin therapy is
important. In addition, the nurse could assess the patient for signs of
hyperthyroidism such as fatigue, increased appetite, weight loss, heat
intolerance, and tachycardia (heart rate > 100 beats/min). However, no
other clinical indicators would suggest hyperthyroidism in this patient. The
nurse should assess for evidence of dehydration by looking at skin turgor (if
the skin appears soft or “floppy,” then dehydration is present) and mucous
membranes (dry lips).
|
Stroke
prevention: State
the CHADS2-Vasc score, how it was calculated, and general recommendation for
anticoagulation (Table 1 in Tackling, 2019); assuming no contraindications,
describe potential treatments for anticogulation the nurse should expect to
be ordered. (15 points)
|
A CHADS2-VASc score is a tool that can be used to monitor the risk
of stroke in patients with atrial fibrillation (A.F.). It was developed by
Tackling et al., 2019 and is based on age, prior stroke or transient ischemic
attack (TIA), heart failure; diabetes mellitus; and systolic blood pressure
greater than 140 mm Hg. The formula is as follows: CHADS2-Vasc = [0 + 0 + 1 +
1] x 2 = 4 points. If you had a patient who scored 4 points on this scale,
they would have an increased risk for stroke (Nadadur et al., 2016).
Anticoagulants such as warfarin or aspirin are often used to prevent strokes
in patients with A.F. The CHADS2-Vasc score was calculated using the
following variables: age ≥75 years, hypertension (HTN), diabetes mellitus (D.M.),
prior stroke or transient ischemic attack (TIA), and cardiac failure or
ventricular arrhythmia (A.F.). The scores range from 0 to 6; a higher score
indicates an increased risk of stroke. For example, if a patient has a
CHADS2-Vasc score of 1, they are at low risk of stroke; if they have a
CHADS2-Vasc score of 2 or greater, they are at moderate risk of stroke.
CHADS2-Vasc Score = (0 - 1) + (1 point for each)
Age ≥ 78 years 0 points
Symptoms of heart failure 0 points c
0 points d for systolic bp of 140 mm Hg or diastolic bp of 90 mm Hg
The patient has a history of atrial fibrillation and is at
high risk for stroke. Therefore, the nurse should expect to be ordered
heparin therapy and aspirin therapy (Nadadur et al., 2016).
The patient has a history of hypertension, which means
that his blood pressure may fluctuate during treatment. The nurse should be
ordered oral antihypertensive medications and subcutaneous antihypertensive
medications (e.g., angiotensin-converting enzyme inhibitors or angiotensin
receptor blockers). Moreover, the patient has diverticulitis; therefore, the
nurse should expect to be ordered antibiotics (e.g., ciprofloxacin) if
needed, increased fiber intake in the diet
|
Rate
and rhythm control: Assuming
no contraindications, describe specific treatments for rate and rhythm
control of AFIB the nurse should expect to be
ordered. (20 points)
|
Rate control. The first line of therapy for rate control
is beta-blockers. Beta-blockers are recommended for most patients with AFIB
and are the most effective agents for controlling the heart rate (H.R.).
Beta-blockers reduce H.R. by affecting both sympathetic and parasympathetic
nerve activity. The exact mechanism of action of beta-blockers on H.R.
depends upon which receptor they bind to, but they all lower H.R. by
decreasing sympathetic activity and increasing vagal tone. This results in a
decrease in cardiac contractility. The American Heart Association recommends
beta-blockers as first-line therapy for rate control (Nadadur, 2016). A
recent meta-analysis found that beta-blockers were significantly better than
calcium channel blockers at reducing H.R.s, although the difference was not
significant [4]. Beta-blockers do not have any significant adverse effects on
mortality or morbidity for patients with AFIB.
Amiodarone (IV or oral) is usually given as a first-line
agent for rate control if there are no contraindications. It can be used as a
bridge to other medications or combined.
Rhythm control:
- Diltiazem IV - may be used for rate control before
cardioversion if AFIB is not ventricular tachycardia (V.T.).
- Verapamil IV - may be used for rate control before
cardioversion if AFIB is not V.T. (Ganz, 2019).
Amiodarone IV can be used with diltiazem/verapamil for
rhythm control and rate control.
|
Nursing
education: Based
on the patient’s modifiable risk factors for AFIB, identify areas for risk
reduction education that should be provided by the nurse? (20 points)
|
Risk reduction education for AFIB: Low-salt diet,
exercise, and weight loss are recommended for patients with hypertension.
Patients with diabetes mellitus should follow their prescribed diet and
exercise program. A low-fat diet benefits all patients, particularly those
with elevated cholesterol levels or triglycerides. Alcohol consumption should
be limited, especially in those with hypertension or diabetes mellitus.
Cigarette smoking increases the risk of cardiovascular disease, including
stroke and peripheral vascular disease (PVD).
Risk reduction education for hypothyroidism:
Hypothyroidism occurs when the thyroid gland does not produce enough
hormones; this condition is often accompanied by weight gain and fatigue
(American Heart Association). Patients should be informed that hypothyroidism
may cause abnormal heart rhythms (e.g., atrial fibrillation). They should
also be informed about untreated hypothyroidism’s potential consequences,
such as heart failure and other cardiovascular problems.
Lifestyle change: Smoking (smoking increases the risk of
developing AFIB). Alcohol use (alcohol use can cause dehydration and can
increase blood pressure). Diet (high salt intake can increase blood pressure)
(Ganz, 2019). Weight loss (obesity is a modifiable risk factor for AFIB).
Exercise (exercise reduces stress and improves cardiovascular function).
Reduce sodium intake to less than 2,300 mg/day
Avoid excessive alcohol consumption and excessive caffeine
consumption (Laforest et al., 2019).
Exercise regularly (at least 30 minutes of aerobic
activity three times per week)
|
Scholarly
writing (15 points)
|
|
References
Ganz,. (2019) L. I. GRAPHICS View All.
Laforest, B., Dai, W., Tyan, L., Lazarevic, S., Shen, K. M.,
Gadek, M., ... & Moskowitz, I. P. (2019). Atrial fibrillation risk loci
interact to modulate Ca 2+-dependent atrial rhythm homeostasis. The Journal of clinical investigation, 129(11), 4937-4950.
Nadadur, R. D., Broman, M. T., Boukens, B., Mazurek, S. R.,
Yang, X., Van Den Boogaard, M., ... & Moskowitz, I. P. (2016). Pitx2
modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm. Science translational medicine, 8(354), 354ra115-354ra115.
Mayyas, F., Niebauer, M., Zurick, A., Barnard, J., Gillinov,
A. M., Chung, M. K., & Van Wagoner, D. R. (2010). Association of left
atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with
structural heart disease. Circulation:
Arrhythmia and Electrophysiology, 3(4),
369-379.
Tacklind, C. (2019). Guideline-based Management of Patients
With Atrial Fibrillation. The Journal for
Nurse Practitioners, 15(1),
54-59.